Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
月曜日, 8 24

DaVita Inc

DVANYSE
Trade with Public
Trade with Public
$176.50
2.681.54%
近くで: Aug 24, 5:00 PM EST
$176.50
N/A
時間外: 4:00 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

DaVita Financials

DaVita (DVA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
DaVita Affirms FY2026 Adj EPS Guidance of $14.10-$15.20 vs $14.82 Est

DaVita (NYSE:DVA) affirms FY2026 Adj EPS guidance from $14.10-$15.20 to $14.10-$15.20 vs $14.82 analyst estimate..
Benzinga Newsdesk

PRO
DaVita Q2 Adj. EPS $4.02 Beats $3.88 Estimate, Sales $3.554B Beat $3.496B Estimate

DaVita (NYSE:DVA) reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $3.88 by 3.61 percent. This is a 36.27 percent increase over earnings of $2.95 per share from the same period
Benzinga Newsdesk

PRO
DaVita Raises FY2026 Adj EPS Guidance from $13.60-$15.00 to $14.10-$15.20 vs $13.98 Est

DaVita (NYSE:DVA) raises FY2026 Adj EPS guidance from $13.60-$15.00 to $14.10-$15.20 vs $13.98 analyst estimate..
Benzinga Newsdesk

PRO
DaVita Q1 Adj. EPS $2.87 Beats $2.32 Estimate, Sales $3.416B Beat $3.356B Estimate

DaVita (NYSE:DVA) reported quarterly earnings of $2.87 per share which beat the analyst consensus estimate of $2.32 by 23.71 percent. This is a 43.5 percent increase over earnings of $2.00 per share from the same period
Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

DaVita Stock Rallies On Profit Beat, Confident 2026 View

DaVita stock surged after the kidney care provider beat earnings estimates and issued strong 2026 guidance, signaling stable treatment volumes, higher reimbursement rates, and an improving income outlook.
Vandana Singh

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved